Tag Archives: multifocal leukoencophalopathy

There has been a lot of controversy about the Multiple Sclerosis drug Tysabri since it was first approved by the Food and Drug Administration (FDA) in November, 2004. Patients were convinced they’d found a miracle drug, and Tysabri was being tested for effectiveness in treating Crohn’s disease. Then, three months from the date of its … Continue reading